What is in this article?:
- From Sanofi to Kaneka, global attention turns to India
- NBJ Bottom Line
A raft of global nutrition deals went live in India this summer, highlighting the emergence of the subcontinent as the new nutrition market to watch.
Diverse companies have made inroads into India’s nutrition industry this summer. On August 24, Paris-based pharmaceutical conglomerate Sanofi Group announced its agreement to purchase the nutraceuticals segment of India’s Universal Medicare Ltd. for US$109 million, according to Reuters.
Earlier this month, on the other side of the world, Osaka-based Kaneka Corporation, chemicals manufacturer and CoQ10 supplier, inked a partnership with Hydride Ion Corporation (HIC) to distribute supplements through Generix Lifesciences, a Delhi-based firm. Generix proffers raw materials to pharmaceutical companies, and has created a new division, Genlife, to market four products from Kaneka and one from HIC in India.
